Press release
Pharmacogenomics Market Analysis and Forecast to 2033: Market Opportunities, Trends, and Pricing Analysis
For More Information: https://evolvebi.com/report/pharmacogenomics-market-analysis/
The report includes 10 key players in the Pharmacogenomics market ecosystem that have been strategically profiled, along with the market ranking/share for major players. The key players profiled in the report are:
• Abbott Laboratories
• Admera Health
• Dynamic DNA Laboratories
• Empire Genomics
• Hoffmann-La Roche Ltd
• Illumina Inc
• OneOme
• Myriad Genetics Inc
• OPKO Health Inc
• Invitae
• Thermo Fisher Scientific Inc
The Pharmacogenomics Market is highly competitive, with key players focusing on genetic testing, precision medicine, and advanced diagnostics to enhance personalized treatment options. Abbott Laboratories, Hoffmann-La Roche Ltd, Illumina Inc, and Thermo Fisher Scientific Inc lead the market with their strong portfolios in genetic sequencing, molecular diagnostics, and bioinformatics solutions. Companies like Myriad Genetics Inc, Admera Health, and OneOme specialize in comprehensive genetic testing services for various therapeutic areas, including oncology and cardiology. Empire Genomics and Dynamic DNA Laboratories provide targeted genomic solutions for clinical and research applications. OPKO Health Inc and Invitae are expanding their market reach by offering cost-effective genetic testing services, making pharmacogenomics more accessible. The market is driven by technological advancements, strategic partnerships, and increasing investments in genomic research, positioning these companies at the forefront of precision medicine innovation.
For sample report pages - https://evolvebi.com/report/pharmacogenomics-market-analysis/
Market Segment By Technology with focus on market share, consumption trend, and growth rate of Pharmacogenomics Market:
o Next Generation Sequencing
o Polymerase Chain Reaction
o Gel electrophoresis
o Mass Spectrometry
o Microarray
o Others
Market Segment By Application with focus on market share, consumption trend, and growth rate of Pharmacogenomics Market:
o Cardiovascular disease
o Infectious diseases
o Oncology
o Neurological diseases
o Psychiatry
o Others
Market Segment By End-User with a focus on market share, consumption trend, and growth rate of Pharmacogenomics Market:
o Hospitals and clinics
o Research institutions
o Academic institutes
Global Pharmacogenomics Geographic Coverage:
• North America
o US
o Canada
o Mexico
• Europe
o UK
o Germany
o France
o Italy
o Spain
o Benelux
o Nordic
o Rest of Europe
• Asia Pacific
o China
o Japan
o South Korea
o Indonesia
o Austalia
o Malaysia
o India
o Rest of Asia Pacific
• South America
o Brazil
o Argentina
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Egypt
o South Africa
o Rest of the Middle East & Africa
For any customization, contact us through - https://evolvebi.com/report/pharmacogenomics-market-analysis/
Key Matrix for Latest Report Update
• Base Year: 2023
• Estimated Year: 2024
• CAGR: 2024 to 2034
Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/
About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from fortune's global 2000 companies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Pharmacogenomics Market Analysis and Forecast to 2033: Market Opportunities, Trends, and Pricing Analysis here
News-ID: 3885672 • Views: …
More Releases from Evolve Business Intelligence
Plant-Based Meat Market Forecast to Reach USD 26.98 Billion by 2033
The plant-based meat market is at a pivotal point, marked by strong growth in the past decade but now facing headwinds. While traditional retail channels have seen recent slowdowns, the non-store-based segment, which includes direct-to-consumer (D2C) e-commerce, meal kits, and food service, presents a significant and largely untapped opportunity. This channel allows brands to bypass the challenges of traditional retail, such as intense competition for shelf space and high listing…
Nuclear Power Plant Market Forecast to Reach USD 40.75 Billion by 2033
As the world seeks a clean, reliable, and sustainable energy future, High Temperature Gas-Cooled Reactors (HTGRs) are emerging as a prime candidate to lead the next generation of nuclear power. This advanced reactor technology, which uses a graphite-moderated core and inert helium coolant, offers a unique blend of inherent safety and versatility that extends well beyond traditional electricity generation. While challenges remain, the opportunity for HTGRs to transform the nuclear…
LED Lighting Market Forecast to Reach USD 255.92 Billion by 2035
The global LED lighting market is on a trajectory of significant expansion, fueled by the rising demand for energy-efficient and sustainable lighting solutions. While the market for LED lamps remains strong, luminaires-complete lighting fixtures with integrated LEDs-are emerging as the primary driver of future growth. Valued at an estimated USD 71.59 billion in 2023, the market is projected to surge to over USD 255.92 billion by 2035, with a compound…
Sensor Market Forecast to Reach USD 457.26 Billion by 2032
The global sensor market is at a pivotal point, poised for remarkable growth driven by the proliferation of smart devices, industrial automation, and the Internet of Things (IoT). The market, valued at an estimated USD 241.06 billion in 2024, is projected to expand significantly to approximately USD 457.26 billion by 2032, demonstrating a robust Compound Annual Growth Rate (CAGR) of about 8.5%. Within this dynamic landscape, a key player is…
More Releases for Pharmacogenomics
Pharmacogenomics - Top Companies Regional and Data Analysis
Pharmacogenomics is a branch of science, which studies the role of gene over the activity of a drugs and hence helps the refreshers in predicting the response of novel as well as previously available therapies.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00007564/?utm_source=OpenPR&utm_medium=10129
Major Companies operating in the Pharmacogenomics Market are:
• F. Hoffmann-la Roche Ltd
• Abbott
• Oxford Nanopore Technologies
• Thermo Fisher Scientific Inc.
• Illumina, Inc.
• QIAGEN
• Agilent Technologies, Inc.
• Myriad Genetics, Inc.
• Admera Health
Contact Us:
If you have any queries about…
Pharmacogenomics Market worth $5.8 billion by 2028
North America region is witnessing increasing investments and research activities in the field of drug discovery and development. The need for advanced therapies due to rising rate of cancer has contributed to growth of the pharmacogenomics market.
Pharmacogenomics Market [https://www.marketsandmarkets.com/Market-Reports/pharmacogenomics-market-142682251.html?utm_source=ABnewswire&utm_campaign=Paid&utm_content=Referral] in terms of revenue was estimated to be worth $3.5 billion in 2023 and is poised to reach $5.8 billion by 2028, growing at a CAGR of 10.6% from 2023 to…
Genetic Medicine: Unveiling the Power of Pharmacogenomics
Based on technology, the pharmacogenomics market is segmented into PCR, sequencing, microarray, gel electrophoresis, mass spectrometry, and others. The market for the PCR segment is subsegmented into real time PCR, standard PCR, and digital PCR. The PCR segment dominated the pharmacogenomics market in 2021 and is expected to register the highest CAGR during the forecast period.
Download Sample PDF Details at: https://www.theinsightpartners.com/sample/TIPRE00007564?utm_source=OpenPR&utm_medium=10776
The pharmacogenomics market is segmented on the basis of…
Complete PDF Guide On Pharmacogenomics [PDF]
According to our latest study on "Pharmacogenoics Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Technology, Application, and End User," the market is projected to reach US$ 14,107.80 million by 2028 from US$ 7,087.81 million in 2021; it is expected to grow at a CAGR of 10.3% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their…
Global Pharmacogenomics Market Size & Trends
According to a new market research report published by Global Market Estimates, the global pharmacogenomics market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The growth of the global pharmacogenomics market is driven by advancements in genomics and DNA sequencing technologies, the rising demand for personalized medicine, regulatory support from agencies like the FDA, cost-effectiveness through reduced adverse reactions, and a growing aging population with complex…
Global Pharmacogenomics Services Market Insights | 2022-2032
The Pharmacogenomics Services Market refers to the services provided by companies and laboratories that offer personalized medicine based on a patient's genetic makeup. Pharmacogenomics is the study of how an individual's genes affect their response to certain drugs, and the pharmacogenomics services market focuses on utilizing this knowledge to optimize drug therapy.
These services typically involve genetic testing to identify specific genetic variations that may impact a patient's response to certain…
